Trials / Sponsors / Anza Therapeutics, Inc.
Anza Therapeutics, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Study of Safety and Tolerability of Multiple Intravenous Doses of ANZ-521 in Adults With Chronic Hepatitis C V Chronic Hepatitis C | Phase 1 / Phase 2 | 2008-11-01 |
| Terminated | Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Malignant Epithelial Mesothelioma, Adenocarcinoma of the Pancreas, Carcinoma, Non-Small-Cell Lung | Phase 1 | 2007-12-01 |
| Completed | Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases Neoplasm Metastasis, Liver Neoplasms, Carcinoma | Phase 1 | 2006-10-01 |